SYNTOCINON Side Effects

6534215-3 | Pneumonitis, Vaginal Haematoma
on Dec 28, 2009 Female patient from UNITED KINGDOM , 20 years of age, was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis, vaginal haematoma. Syntocinon dosage: .

6496380-6 | Caesarean Section, Normal Newborn, Obstructed Labour, Postpartum Haemorrhage, Uterine Atony, Uterine Rupture
Patient was taking Syntocinon (View Usage). Patient had the following side effects: caesarean section, normal newborn, obstructed labour, postpartum haemorrhage, uterine atony, uterine rupture on Nov 30, 2009 from AUSTRALIA Additional patient health information: Female patient , 31 years of age, . Syntocinon dosage: 10 Iu. During the same period patient was treated with SYNTOMETRINE (500 Ig) (View Syntometrine Review and Syntometrine Label ), OXYTOCIN (View Oxytocin Review and Oxytocin Label ), PROSTAGLANDIN F2 ALPHA (View Prostaglandin F2 Alpha Review and Prostaglandin F2 Alpha Label ).

6422160-3 | Alanine Aminotransferase Increased, Allergy Test Positive, Anaphylactic Reaction, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Immunoglobulin E Increased, Blood Pressure Decreased, Blood Urine Present, Brain Oedema
Adverse event was reported on Feb 17, 2009 by a Female patient taking Syntocinon (View Usage) (Dosage: 5 U, Bolus) was diagnosed with hypertension and. Location: INDIA , 34 years of age, weighting 187.4 lb, After Syntocinon was administered, patient had the following side effects: alanine aminotransferase increased, allergy test positive, anaphylactic reaction, aspartate aminotransferase increased, blood creatinine increased, blood immunoglobulin e increased, blood pressure decreased, blood urine present, brain oedema. During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), METHYLDOPA (500 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), LABETALOL (100 Mg, Bid) (View Labetalol Review and Labetalol Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (50 Ug Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NORMAL SALINE (500 Ml) (View Normal Saline Review and Normal Saline Label ), DEXTROSE (View Dextrose Review and Dextrose Label ). Patient was hospitalized.

6348730-9 | Anaphylactic Reaction, Cardiac Arrest, Resuscitation
on Sep 07, 2009 Female patient from SLOVENIA , 22 years of age, was diagnosed with caesarean section, prophylaxis, spinal anaesthesia, hypotension and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, cardiac arrest (What is cardiac arrest?), resuscitation. Syntocinon dosage: 5 Iu/l, Unk. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (1.2 G, Unk) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), DIAMORPHINE (Unk) (View Diamorphine Review and Diamorphine Label ), LIGNOCAINE (3 Ml, Unk) (View Lignocaine Review and Lignocaine Label ), MARCAINE (Unk) (View Marcaine Review and Marcaine Label ), PHENYLEPHRINE (100 Ug, Unk) (View Phenylephrine Review and Phenylephrine Label ). Patient was hospitalized.


6239299-8 | Hysterectomy, Postpartum Haemorrhage
on Mar 24, 2009 Female patient from COLOMBIA , 30 years of age, was diagnosed with uterine atony and was treated with Syntocinon (View Usage). Patient had the following side effects: hysterectomy (What is hysterectomy?), postpartum haemorrhage. Syntocinon dosage: 40 Ul, Once/single. During the same period patient was treated with METHERGINE (Unk) (View Methergine Review and Methergine Label ), MISOPROSTOL (Unk) (View Misoprostol Review and Misoprostol Label ).

6108391-0 | Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Haemoglobin Decreased, Histology Abnormal, Hysterectomy, Postpartum Haemorrhage, Uterine Atony
Patient was taking Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: activated partial thromboplastin time prolonged, caesarean section, haemoglobin decreased, histology abnormal, hysterectomy (What is hysterectomy?), postpartum haemorrhage, uterine atony on Feb 23, 2009 from COLOMBIA Additional patient health information: Female patient , 30 years of age, was diagnosed with induced labour, postpartum haemorrhage, uterine atony and. Syntocinon dosage: 3iu. During the same period patient was treated with METHERGINE (0.2 Mg, Unk) (View Methergine Review and Methergine Label ), MISOPROSTOL (400 Ug, Unk) (View Misoprostol Review and Misoprostol Label ).

6107129-0 | Arrested Labour, Caesarean Section, Hypovolaemic Shock, Hysterectomy, Postpartum Haemorrhage, Uterine Atony
Adverse event was reported on Feb 23, 2009 by a Female patient taking Syntocinon (View Usage) (Dosage: 15 U, Unk) was diagnosed with labour induction, uterine atony, postpartum haemorrhage and. Location: COLOMBIA , 25 years of age, Patient experienced the following unwanted or unexpected effects: arrested labour, caesarean section, hypovolaemic shock, hysterectomy (What is hysterectomy?), postpartum haemorrhage, uterine atony. During the same period patient was treated with DEXTROSE (View Dextrose Review and Dextrose Label ), METHERGINE (View Methergine Review and Methergine Label ), MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), MORPHINE (View Morphine Review and Morphine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CEFALOZIN (View Cefalozin Review and Cefalozin Label ).

6107123-X | Hysterectomy, Postpartum Haemorrhage, Uterine Atony
on Feb 23, 2009 Female patient from COLOMBIA , 30 years of age, was diagnosed with induced labour and was treated with Syntocinon (View Usage). Patient had the following side effects: hysterectomy (What is hysterectomy?), postpartum haemorrhage, uterine atony. Syntocinon dosage: 20 Ui Per Continuous Infusion. During the same period patient was treated with METHERGINE (0.2 Mg) (View Methergine Review and Methergine Label ), MISOPROSTOL (800 Mcg) (View Misoprostol Review and Misoprostol Label ), CEFALOZIN (View Cefalozin Review and Cefalozin Label ), MORPHINE (View Morphine Review and Morphine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ). Patient was hospitalized.

6094628-3 | Hysterectomy, Postpartum Haemorrhage
on Feb 23, 2009 Female patient from COLOMBIA , 30 years of age, was diagnosed with uterine atony and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: hysterectomy (What is hysterectomy?), postpartum haemorrhage. Syntocinon dosage: Injection 40 Ul, Once/single. During the same period patient was treated with METHERGINE (Unk) (View Methergine Review and Methergine Label ), MISOPROSTOL (Unk) (View Misoprostol Review and Misoprostol Label ).

6086480-7 | Hysterectomy, Postpartum Haemorrhage
Patient was taking Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: hysterectomy (What is hysterectomy?), postpartum haemorrhage on Feb 17, 2009 from COLOMBIA Additional patient health information: Female patient , 30 years of age, was diagnosed with uterine atony and. Syntocinon dosage: Injection 40 Ul, Once/single. During the same period patient was treated with METHERGINE (Unk) (View Methergine Review and Methergine Label ), MISOPROSTOL (Unk) (View Misoprostol Review and Misoprostol Label ).

6085742-7 | Alanine Aminotransferase Increased, Allergy Test Positive, Anaphylactic Reaction, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Immunoglobulin E Increased, Blood Pressure Decreased, Blood Urine Present, Brain Oedema
Adverse event was reported on Feb 17, 2009 by a Female patient taking Syntocinon (View Usage) (Dosage: 5 U, Bolus) was diagnosed with hypertension and. Location: INDIA , 34 years of age, weighting 187.4 lb, Patient had the following side effects: alanine aminotransferase increased, allergy test positive, anaphylactic reaction, aspartate aminotransferase increased, blood creatinine increased, blood immunoglobulin e increased, blood pressure decreased, blood urine present, brain oedema. During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), METHYLDOPA (500 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), LABETALOL HCL (100 Mg, Bid) (View Labetalol Hcl Review and Labetalol Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), THYROXINE (50 Ug Daily) (View Thyroxine Review and Thyroxine Label ), SODIUM CHLORIDE (500 Ml) (View Sodium Chloride Review and Sodium Chloride Label ), DEXTROSE (View Dextrose Review and Dextrose Label ). Patient was hospitalized.

6085726-9 | Precocious Puberty
on Feb 11, 2009 Female patient from DENMARK , child 8 years of age, was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: precocious puberty. Syntocinon dosage: .

5954711-7 | Suture Insertion
on Nov 13, 2008 Female patient from AUSTRALIA , 25 years of age, was diagnosed with caesarean section and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: suture insertion. Syntocinon dosage: 20 Iu/day.

5954706-3 | Hysterectomy, Placenta Accreta
Patient was taking Syntocinon (View Usage). Patient had the following side effects: hysterectomy (What is hysterectomy?), placenta accreta on Nov 13, 2008 from AUSTRALIA Additional patient health information: Female patient , 29 years of age, was diagnosed with caesarean section and. Syntocinon dosage: 20 Iu.

5949431-9 | Cerebral Palsy, Foetal Distress Syndrome
Adverse event was reported on Nov 03, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: ) . Location: IRELAND , child 7 years of age, After Syntocinon was administered, patient had the following side effects: cerebral palsy, foetal distress syndrome.

5937110-3 | Brain Injury, Cerebral Palsy, Foetal Distress Syndrome, Head Injury, Life Expectancy Shortened, Movement Disorder, Muscle Spasticity, Resuscitation
on Oct 22, 2008 Female patient from IRELAND , child 7 years of age, was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: brain injury, cerebral palsy, foetal distress syndrome, head injury, life expectancy shortened, movement disorder (What is movement disorder?), muscle spasticity, resuscitation. Syntocinon dosage: .

5871793-1 | Abscess, Abscess Drainage, Aspiration Pleural Cavity, Bacteroides Infection, Beta Haemolytic Streptococcal Infection, Caesarean Section, Chorioamnionitis, Dyspnoea, Hepatic Enzyme Increased
on Aug 27, 2008 Female patient from HONG KONG , 22 years of age, was treated with Syntocinon (View Usage). Patient had the following side effects: abscess (What is abscess?), abscess drainage, aspiration pleural cavity, bacteroides infection, beta haemolytic streptococcal infection, caesarean section, chorioamnionitis, dyspnoea, hepatic enzyme increased. Syntocinon dosage: . During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ). Patient was hospitalized.

5843239-0 | Escherichia Infection, Sepsis, Vaginal Haemorrhage
Patient was taking Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: escherichia infection, sepsis (What is sepsis?), vaginal haemorrhage on Aug 05, 2008 from SINGAPORE Additional patient health information: Female patient , 31 years of age, . Syntocinon dosage: . During the same period patient was treated with DURATOCIN (View Duratocin Review and Duratocin Label ), BLOOD AND RELATED PRODUCTS (View Blood And Related Products Review and Blood And Related Products Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

5756560-1 | Grand Mal Convulsion
Adverse event was reported on May 26, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: 5 Iu/ml) . Location: FRANCE , 30 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion.

5723144-0 | Uterine Atony
on Apr 28, 2008 Female patient from PORTUGAL , 34 years of age, was treated with Syntocinon (View Usage). Patient had the following side effects: uterine atony. Syntocinon dosage: .

5720823-6 | Blood Pressure Decreased, Haemoglobin Decreased, Massage, Metrorrhagia, Postpartum Haemorrhage, Uterine Atony, Uterine Dilation And Evacuation
on Apr 23, 2008 Female patient from FRANCE , 37 years of age, was diagnosed with induced labour, local anaesthesia and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: blood pressure decreased, haemoglobin decreased, massage, metrorrhagia, postpartum haemorrhage, uterine atony, uterine dilation and evacuation. Syntocinon dosage: 5 Iu At 15ml/hr Then 30ml/hr From 10:40 On. During the same period patient was treated with PROPESS (1 Df, Once/single) (View Propess Review and Propess Label ), ATARAX (1 Df, Once/single) (View Atarax Review and Atarax Label ), XYLOCAINE (1 Df, Once/single) (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

5720818-2 | Massage, Postpartum Haemorrhage, Uterine Atony
Patient was taking Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: massage, postpartum haemorrhage, uterine atony on Apr 23, 2008 from FRANCE Additional patient health information: Female patient , 34 years of age, . Syntocinon dosage: 20 Iu, Once/single. During the same period patient was treated with MAG 2 (1 Df, Once/single) (View Mag 2 Review and Mag 2 Label ), SPASFON (2 Df, Once/single) (View Spasfon Review and Spasfon Label ).

5720812-1 | Caesarean Section, Foetal Heart Rate Abnormal, High Foetal Head, Postpartum Haemorrhage, Uterine Atony
Adverse event was reported on Apr 23, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: 5 Iu, Once/single) was diagnosed with uterine atony, epidural anaesthesia and. Location: FRANCE , 41 years of age, Patient had the following side effects: caesarean section, foetal heart rate abnormal, high foetal head, postpartum haemorrhage, uterine atony. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), NAROPEINE (View Naropeine Review and Naropeine Label ), SUFENTA (View Sufenta Review and Sufenta Label ).

5720811-X | Postpartum Haemorrhage, Uterine Atony
on Apr 23, 2008 Female patient from FRANCE , 27 years of age, weighting 235.9 lb, was diagnosed with induced labour and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: postpartum haemorrhage, uterine atony. Syntocinon dosage: 1 Electric Syringe Pump Injection. During the same period patient was treated with PROSTAGLANDINS (View Prostaglandins Review and Prostaglandins Label ).

5719914-5 | Haemoglobin Decreased, Heart Rate Increased, Hypotension, Massage, Postpartum Haemorrhage, Shock Haemorrhagic, Uterine Atony, Uterine Dilation And Evacuation
on Apr 23, 2008 Female patient from FRANCE , 36 years of age, was diagnosed with premature labour and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, heart rate increased, hypotension, massage, postpartum haemorrhage, shock haemorrhagic, uterine atony, uterine dilation and evacuation. Syntocinon dosage: 10 Iu, Unk. During the same period patient was treated with CELESTONE (View Celestone Review and Celestone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5683974-0 | Massage, Postpartum Haemorrhage, Uterine Atony
Patient was taking Syntocinon (View Usage). Patient had the following side effects: massage, postpartum haemorrhage, uterine atony on Mar 20, 2008 from FRANCE Additional patient health information: Female patient , 34 years of age, . Syntocinon dosage: 20 Iu, Once/single. During the same period patient was treated with MAG 2 (1 Df, Once/single) (View Mag 2 Review and Mag 2 Label ), SPASFON (2 Df, Once/single) (View Spasfon Review and Spasfon Label ).

5683968-5 | Blood Pressure Decreased, Haemoglobin Decreased, Massage, Metrorrhagia, Postpartum Haemorrhage, Uterine Atony, Uterine Dilation And Evacuation
Adverse event was reported on Mar 20, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: 5 Iu At 15ml/hr Then 30ml/hr From 10:40 On) was diagnosed with induced labour, local anaesthesia and. Location: FRANCE , 37 years of age, After Syntocinon was administered, patient had the following side effects: blood pressure decreased, haemoglobin decreased, massage, metrorrhagia, postpartum haemorrhage, uterine atony, uterine dilation and evacuation. During the same period patient was treated with PROPESS (1 Df, Once/single) (View Propess Review and Propess Label ), ATARAX (1 Df, Once/single) (View Atarax Review and Atarax Label ), XYLOCAINE (1 Df, Once/single) (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

5683963-6 | Caesarean Section, Foetal Heart Rate Abnormal, High Foetal Head, Postpartum Haemorrhage, Uterine Atony
on Mar 20, 2008 Female patient from FRANCE , 41 years of age, was diagnosed with uterine atony, epidural anaesthesia and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, foetal heart rate abnormal, high foetal head, postpartum haemorrhage, uterine atony. Syntocinon dosage: 5 Iu, Once/single. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), NAROPEINE (View Naropeine Review and Naropeine Label ), SUFENTA (View Sufenta Review and Sufenta Label ).

5678587-0 | Haemoglobin Decreased, Heart Rate Increased, Hypotension, Massage, Postpartum Haemorrhage, Shock Haemorrhagic, Uterine Atony, Uterine Dilation And Evacuation
on Mar 20, 2008 Female patient from FRANCE , 36 years of age, was diagnosed with premature labour and was treated with Syntocinon (View Usage). Patient had the following side effects: haemoglobin decreased, heart rate increased, hypotension, massage, postpartum haemorrhage, shock haemorrhagic, uterine atony, uterine dilation and evacuation. Syntocinon dosage: 10 Iu, Unk. During the same period patient was treated with CELESTONE (View Celestone Review and Celestone Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ). Patient was hospitalized.

5659596-4 | Postpartum Haemorrhage, Uterine Atony
Patient was taking Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: postpartum haemorrhage, uterine atony on Mar 10, 2008 from FRANCE Additional patient health information: Female patient , 27 years of age, weighting 235.9 lb, was diagnosed with induced labour and. Syntocinon dosage: 1 Electric Syringe Pump Injection. During the same period patient was treated with PROSTAGLANDINS (View Prostaglandins Review and Prostaglandins Label ).

5657922-3 | Postpartum Haemorrhage, Uterine Atony
Adverse event was reported on Mar 03, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: 20 Iu, Once/single) was diagnosed with uterine atony and. Location: FRANCE , 41 years of age, Patient experienced the following unwanted or unexpected effects: postpartum haemorrhage, uterine atony.

5657920-X | Postpartum Haemorrhage, Transfusion, Uterine Atony
on Mar 03, 2008 Female patient from FRANCE , 42 years of age, was diagnosed with induced labour and was treated with Syntocinon (View Usage). Patient had the following side effects: postpartum haemorrhage, transfusion, uterine atony. Syntocinon dosage: 5 Iu, Once/single. During the same period patient was treated with PROPESS (View Propess Review and Propess Label ). Patient was hospitalized.

5657907-7 | Postpartum Haemorrhage, Uterine Atony
on Mar 03, 2008 Female patient from FRANCE , 34 years of age, was diagnosed with induced labour and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: postpartum haemorrhage, uterine atony. Syntocinon dosage: 5 Iu, Once/single. During the same period patient was treated with PROPESS (View Propess Review and Propess Label ).

5635961-6 | Postpartum Haemorrhage
Patient was taking Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: postpartum haemorrhage on Feb 13, 2008 from AUSTRALIA Additional patient health information: Female patient , 28 years of age, was diagnosed with postpartum haemorrhage and. Syntocinon dosage: 10 Iu. Patient was hospitalized.

5631790-8 | Haemoglobin Decreased, Postpartum Haemorrhage
Adverse event was reported on Feb 13, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: 10 Iu) . Location: AUSTRALIA , 33 years of age, Patient had the following side effects: haemoglobin decreased, postpartum haemorrhage. During the same period patient was treated with EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), CEPHALEXIN (1 Gm Stat) (View Cephalexin Review and Cephalexin Label ). Patient was hospitalized.

5631787-8 | Haemoglobin Decreased, Postpartum Haemorrhage
on Feb 13, 2008 Female patient from AUSTRALIA , 30 years of age, was diagnosed with third stage postpartum haemorrhage and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: haemoglobin decreased, postpartum haemorrhage. Syntocinon dosage: 10 Iu, Unk. Patient was hospitalized.

5630096-0 | Haemoglobin Decreased, Postpartum Haemorrhage, Surgery, Vulval Haematoma
on Feb 13, 2008 Female patient from AUSTRALIA , 33 years of age, was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, postpartum haemorrhage, surgery (What is surgery?), vulval haematoma. Syntocinon dosage: 10iu. Patient was hospitalized.

5630086-8 | Haemoglobin Decreased, Postpartum Haemorrhage
Patient was taking Syntocinon (View Usage). Patient had the following side effects: haemoglobin decreased, postpartum haemorrhage on Feb 13, 2008 from AUSTRALIA Additional patient health information: Female patient , 39 years of age, was diagnosed with caesarean section and. Syntocinon dosage: 5 Iu. During the same period patient was treated with CEPHALEXIN (1 G Stat) (View Cephalexin Review and Cephalexin Label ), PARACETAMOL (1 G 4 Hourly) (View Paracetamol Review and Paracetamol Label ), VOLTAREN (100 Mg 12 Hourly) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5629818-4 | Postpartum Haemorrhage
Adverse event was reported on Feb 13, 2008 by a Female patient taking Syntocinon (View Usage) (Dosage: Unk, Unk) was diagnosed with ventouse extraction and. Location: AUSTRALIA , 33 years of age, After Syntocinon was administered, patient had the following side effects: postpartum haemorrhage.

5549706-1 | Anaphylactoid Reaction, Angioedema, Blood Pressure Decreased, Blood Pressure Systolic Increased, Eyelid Oedema, Lip Oedema, Tachycardia, Urticaria
on Dec 07, 2007 Female patient from FRANCE , 30 years of age, was diagnosed with assisted delivery and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, angioedema, blood pressure decreased, blood pressure systolic increased, eyelid oedema, lip oedema, tachycardia, urticaria. Syntocinon dosage: 1 Df, Once/single. Patient was hospitalized.

5526246-7 | Caesarean Section, Foetal Monitoring, Meconium In Amniotic Fluid
on Nov 21, 2007 Female patient from SWEDEN , 28 years of age, was diagnosed with labour complication and was treated with Syntocinon (View Usage). Patient had the following side effects: caesarean section, foetal monitoring, meconium in amniotic fluid. Syntocinon dosage: 90 To 20 Ml/h.

5520372-4 | Caesarean Section, Foetal Monitoring, Meconium In Amniotic Fluid
Patient was taking Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: caesarean section, foetal monitoring, meconium in amniotic fluid on Nov 09, 2007 from SWEDEN Additional patient health information: Female patient , 28 years of age, was diagnosed with labour complication and. Syntocinon dosage: 90 To 20 Ml/h.

5488441-5 | Feeling Abnormal, Uterine Dilation And Curettage, Uterine Haemorrhage
Adverse event was reported on Oct 10, 2007 by a Female patient taking Syntocinon (View Usage) (Dosage: ) . Location: BRAZIL , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: feeling abnormal, uterine dilation and curettage, uterine haemorrhage. During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ).

5485167-9 | Caesarean Section
on Oct 09, 2007 Female patient from GERMANY , 23 years of age, was diagnosed with labour stimulation and was treated with Syntocinon (View Usage). Patient had the following side effects: caesarean section. Syntocinon dosage: Unk, Unk. Patient was hospitalized.

5444965-8 | Anaphylactoid Syndrome Of Pregnancy, Foetal Heart Rate Deceleration, Overdose, Uterine Hypertonus, Uterine Spasm
on Sep 05, 2007 Female patient from FRANCE , 32 years of age, was diagnosed with labour induction and was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: anaphylactoid syndrome of pregnancy, foetal heart rate deceleration, overdose, uterine hypertonus, uterine spasm. Syntocinon dosage: . During the same period patient was treated with PROSTINE (View Prostine Review and Prostine Label ).

5430307-0 | Anaphylactoid Syndrome Of Pregnancy, Overdose, Uterine Hypertonus, Uterine Spasm
Patient was taking Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid syndrome of pregnancy, overdose, uterine hypertonus, uterine spasm on Aug 27, 2007 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with labour induction and. Syntocinon dosage: . During the same period patient was treated with PROSTINE (View Prostine Review and Prostine Label ).

5391919-6 | Dissociation, Dizziness, Feeling Hot, Malaise, Presyncope, Vision Blurred
Adverse event was reported on Jul 13, 2007 by a Female patient taking Syntocinon (View Usage) (Dosage: Unk, Unk) was diagnosed with labour induction and. Location: DENMARK , 29 years of age, weighting 231.5 lb, Patient had the following side effects: dissociation, dizziness (What is dizziness?), feeling hot, malaise, presyncope, vision blurred.

5361577-5 | Apnoea, Bradycardia, Hyponatraemia, Oliguria
on Jun 11, 2007 Female patient from UNITED STATES , weighting 5.41 lb, was treated with Syntocinon (View Usage). After Syntocinon was administered, patient had the following side effects: apnoea, bradycardia, hyponatraemia, oliguria. Syntocinon dosage: 5 Iu, Unk. Patient was hospitalized.

5338056-4 | Anaphylactoid Reaction, Angioedema, Blood Pressure Decreased, Blood Pressure Systolic Increased, Eyelid Oedema, Infusion Related Reaction, Lip Oedema, Tachycardia
on May 21, 2007 Female patient from FRANCE , 30 years of age, was diagnosed with assisted delivery and was treated with Syntocinon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, angioedema, blood pressure decreased, blood pressure systolic increased, eyelid oedema, infusion related reaction, lip oedema, tachycardia. Syntocinon dosage: 1 Df, Once/single. Patient was hospitalized.

5284350-5 | Obstetrical Pulmonary Embolism, Overdose, Uterine Hypertonus
Patient was taking Syntocinon (View Usage). Patient had the following side effects: obstetrical pulmonary embolism, overdose, uterine hypertonus on Mar 30, 2007 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with assisted delivery and. Syntocinon dosage: .